These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3912607)
21. [Chronic familial bronchopneumopathies and homozygotic deficiency of alpha-1-antitrypsin]. Vidal J; Cazal P; Robinet-Levy M; Michel FB Poumon Coeur; 1971; 27(1):79-94. PubMed ID: 5555976 [No Abstract] [Full Text] [Related]
22. Alpha-1-proteinase inhibitor: a European overview. Robalo-Cordeiro AJ Eur J Respir Dis; 1987 May; 70(5):261-5. PubMed ID: 3301383 [No Abstract] [Full Text] [Related]
23. Proteases and antiproteases in the lung. Am Rev Respir Dis; 1983 Feb; 127(2):S1-58. PubMed ID: 6338778 [No Abstract] [Full Text] [Related]
24. Genetics of chronic obstructive pulmonary diseases. Searching for their heterogeneity. Kauffmann F Bull Eur Physiopathol Respir; 1984; 20(2):163-210. PubMed ID: 6372904 [No Abstract] [Full Text] [Related]
25. [Polymorphism of protein systems and individual predisposition to broncho-pulmonary occupational diseases (literature review)]. Kuz'mina LP Med Tr Prom Ekol; 1999; (5):28-31. PubMed ID: 10424077 [No Abstract] [Full Text] [Related]
26. Natural history of alpha-1-protease inhibitor deficiency. Hutchison DC Am J Med; 1988 Jun; 84(6A):3-12. PubMed ID: 3289386 [TBL] [Abstract][Full Text] [Related]
27. alpha 1-Antitrypsin deficiency. Catz EG; Speir WA South Med J; 1984 Apr; 77(4):479-83. PubMed ID: 6324384 [TBL] [Abstract][Full Text] [Related]
28. The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin. Fagerhol MK; Cox DW Adv Hum Genet; 1981; 11():1-62, 371-2. PubMed ID: 6168185 [No Abstract] [Full Text] [Related]
29. [Blood proteolytic enzyme inhibitors and their clinical study]. Veremeenko KN; Kizim AI Vopr Med Khim; 1975; 21(1):5-13. PubMed ID: 1091093 [TBL] [Abstract][Full Text] [Related]
31. [Proteolysis and obstructive pulmonary emphysema]. Reichert R; Hochstrasser K; Hochgesand K MMW Munch Med Wochenschr; 1974 Jan; 116(4):173-6. PubMed ID: 4206050 [No Abstract] [Full Text] [Related]
32. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways. Kuhn C J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671 [TBL] [Abstract][Full Text] [Related]
33. [Phenotypes of the alpha-1 proteinase inhibitor in septic diseases and leukemia in children]. Basis VIu; Stakishaĭtis DV; Bumialis VV; Ragialenie LA Lab Delo; 1989; (4):17-9. PubMed ID: 2470956 [TBL] [Abstract][Full Text] [Related]
34. [Genetic and acquired alpha 1-antitrypsin deficiency and development of pulmonary emphysema]. Pedersen CF Ugeskr Laeger; 1984 Sep; 146(37):2770-2. PubMed ID: 6334920 [No Abstract] [Full Text] [Related]
35. Alpha 1 -antitrypsin deficiency as an indicator of susceptibility to pulmonary disease. Mittman C; Barbela T; Lieberman J J Occup Med; 1973 Jan; 15(1):33-8. PubMed ID: 4684725 [No Abstract] [Full Text] [Related]
36. [Proteases, antiproteases, lung emphysema and other smoking damage]. Sehayek E; Halkin H Harefuah; 1989 Aug; 117(3-4):98-9. PubMed ID: 2680831 [No Abstract] [Full Text] [Related]
37. The role of proteolytic enzymes in the pathogenesis of emphysema. Atkinson GW Ann Clin Lab Sci; 1973; 3(5):345-52. PubMed ID: 4543240 [No Abstract] [Full Text] [Related]